Inverse benefit law

From Wikipedia, the free encyclopedia
Jump to: navigation, search

The inverse benefit law states that the more a new drug is marketed, the worse it is for patients. More precisely, the ratio of benefits to harms among patients taking new drugs tends to vary inversely with how extensively a drug is marketed. Two Americans, Howard Brody and Donald Light, have defined the inverse benefit law, inspired by Tudor Hart's inverse care law.[1]

See also[edit]


  1. ^ Brody H, Light DW. The inverse benefit law: how drug marketing undermines patient safety and public health. Am J Public Health. 2011; 101(3):399-404.[dead link][dead link]

External links[edit]